Salix 5% Injection

Supplied By: Merck (710461)


SKU
001551


Unit of
Measure
50mL


Pack
Type
Vial


Case
Qty
1

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Oct- 2025 Sep- 2025 Aug- 2025 Jul- 2025 Jun- 2025 May- 2025 Apr- 2025 Mar- 2025 Feb- 2025 Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024
{{purchaseHistoryItem}}


SKU
001551


Size
50mL

Case
Qty
1

Purchase History

Oct- 2025 {{productPurchaseHistory['001551'][0]}} Mar- 2025 {{productPurchaseHistory['001551'][0+7]}}
Sep- 2025 {{productPurchaseHistory['001551'][1]}} Feb- 2025 {{productPurchaseHistory['001551'][1+7]}}
Aug- 2025 {{productPurchaseHistory['001551'][2]}} Jan- 2025 {{productPurchaseHistory['001551'][2+7]}}
Jul- 2025 {{productPurchaseHistory['001551'][3]}} Dec- 2024 {{productPurchaseHistory['001551'][3+7]}}
Jun- 2025 {{productPurchaseHistory['001551'][4]}} Nov- 2024 {{productPurchaseHistory['001551'][4+7]}}
May- 2025 {{productPurchaseHistory['001551'][5]}} Oct- 2024 {{productPurchaseHistory['001551'][5+7]}}
Apr- 2025 {{productPurchaseHistory['001551'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

SALIX is indicated for the treatment of edema, (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema. It is an effective diuretic possessing a wide therapeutic range. Pharmacologically it promotes the rapid removal of abnormally retained extracellular fluids.

Features & Benefits

  • High potency for effective diuresis
  • Predictable performance with high therapeutic index
  • Diuresis begins within 5 minutes of intravenous administration and within 1 hour of oral administration
  • Furosemide, injectable solution, 5% (50 mg/mL)